Back

Clinical effectiveness of new oral anticoagulants in US and Europe for stroke prevention in atrial fibrillation

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Digging deeper into oral anticoagulants Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Marc Tarsillo

Wallingford (United States of America)

4 More presentations in this session

Presentation thumbnail
Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.
Assistant Professor T. Moumneh (Tours, FR)
Abstract Slides
Presentation thumbnail
Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function
Associate Professor G. Renda (Chieti, IT)
Abstract Slides
Presentation thumbnail
Impact of hemorrhagic events during dual antiplatelet therapy after drug-eluting stent implantation in patients with hemodialysis
Doctor A. Shimizu (Kitakyushu, JP)
Abstract
Presentation thumbnail
Use of vitamin K antagonists in patients aged 85 years or over: analysis of thromboembolic and hemorrhagic events.
Doctor D. Moreira (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Digging deeper into oral anticoagulants

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources